Endotronix, Inc.
USPTO PatentsView assignee record - 26 granted patents across 12 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Endotronix ranks #11,639 of 49,997 tracked US assignees by granted-patent volume, with 26 patents across 12 technology areas.
- #11,639
- of 49,997 US assignees by volume
- Top 23%
- by Innovation Score (45.7/100)
- 22.5
- avg claims per patent
- -15%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R11639 · US Corporation #11,639 · 26 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL
- GRANTS-SMALL 26 grants
- UPPER-Q #11,639/49,997
- PHOTO-FINISH Echo Incorporated
- CPC-FOCUS A61B · 12 areas
- INNOV-PAR 45.7/100
- CLAIMS-DENSE 22.5 claims/avg
- TYPE-USCORP US Corporation
- VEL-DOWN -15% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Echo Incorporated (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Endotronix’s 45.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Endotronix
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Ovivo · near
Ovivo · near
46 score
- X-Card Holdings · near
X-Card Holdings · near
46 score
- Endotronix · this assignee
Endotronix · this assignee
46 score
- Idac Holdings · near
Idac Holdings · near
46 score
- Caterpillar Motoren… · near
Caterpillar Motoren… · near
46 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Endotronix's Innovation Score is 45.7/100 (top 23% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Endotronix?
Each dot is one of Endotronix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Endotronix’s own 22.5 claims/patent is ABOVE the 16.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Endotronix's grants concentrate
Endotronix, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 88.5% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (5 grants) versus a trough of 1 in 2020. By volume, Endotronix sits between Evolutive Labs Co., Ltd. and ExploraMed NC7, Inc..
Endotronix's three-year grant acceleration
Endotronix, Inc. shows 9 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Endotronix's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Evolutive Labs
Evolutive Labs Co., Ltd.
26 patents
- Echo Incorporated
Echo Incorporated
26 patents
- Elopak AS
Elopak AS
26 patents
- Emhart Glass
Emhart Glass S.A.
26 patents
- Energyhub
EnergyHub, Inc.
26 patents
- Ensco Internation…
Ensco International Incorporated
26 patents
- Estimote Polska S…
Estimote Polska Sp z o.o.
26 patents
- Exploramed NC7
ExploraMed NC7, Inc.
26 patents
- Endotronix ◀
Endotronix, Inc.
26 patents
What this shows Endotronix holds 26 patents at rank #11,640, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Endotronix
By rank, the assignees closest to #11,640 in granted patent volume.
- Evolutive Labs Co., Ltd. #11,636 · 26 patents
- Echo Incorporated #11,637 · 26 patents
- Elopak AS #11,638 · 26 patents
- Emhart Glass S.A. #11,639 · 26 patents
- EnergyHub, Inc. #11,641 · 26 patents
- Ensco International Incorporated #11,642 · 26 patents
- Estimote Polska Sp z o.o. #11,643 · 26 patents
- ExploraMed NC7, Inc. #11,644 · 26 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Endotronix's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Endotronix, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Endotronix ranks #784 of 7,127 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (46 here).
Endotronix's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
46 Top 23% higher than 77% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 7.7% |
| 2017 | 2 | 7.7% |
| 2018 | 4 | 15.4% |
| 2019 | 5 | 19.2% |
| 2020 | 1 | 3.8% |
| 2021 | 1 | 3.8% |
| 2022 | 1 | 3.8% |
| 2023 | 5 | 19.2% |
| 2024 | 3 | 11.5% |
| 2025partial year | 2 | 7.7% |
Which technologies does Endotronix, Inc. patent most?
Top 12 of 12 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Endotronix, Inc.'s patent record in context - here's where to go next.
- Endotronix, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 88.5% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #11,639 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Endotronix, Inc. against Evolutive Labs Co., Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 45.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.